768085696	768085696	CD	B-NP	O
|	|	NN	I-NP	O
ECMH	ECMH	NN	I-NP	O
|	|	NN	I-NP	O
14647242	14647242	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9066209	9066209	CD	B-NP	O
|	|	CC	I-NP	O
10/14/2005	10/14/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Attending	Attend	VBG	I-NP	I-protein
evaluation	evaluation	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/22/2005	10/22/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/20/2005	9/20/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BAISCH	BAISCH	NNP	B-NP	O
,	,	,	O	O
SOL	SOL	NNP	B-NP	O
021-25-90-4	021-25-90-4	VBD	B-VP	O
Jer	Jer	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/10/05	10/10/05	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CORNS	CORNS	NN	B-NP	O
,	,	,	O	O
MONROE	MONROE	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALBUTEROL	ALBUTEROL	NN	B-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
NEB	NEB	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
AUGMENTIN	AUGMENTIN	NNP	I-NP	O
250/125	250/125	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMOX	AMOX	NN	I-NP	O
.	.	.	O	O

/	/	SYM	O	B-protein
CLAV.ACID	CLAV.ACID	NN	B-NP	I-protein
250/125	250/125	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
May	May	MD	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
without	without	IN	B-PP	O
regard	regard	NN	B-NP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
VASOTEC	VASOTEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
by	by	IN	B-PP	O
ROUP	ROUP	NN	B-NP	B-protein
,	,	,	O	O
OSWALDO	OSWALDO	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
79599584	79599584	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
good	good	JJ	I-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
K	K	NN	I-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/14/05	7/14/05	CD	B-NP	O
by	by	IN	B-PP	O
ZICKER	ZICKER	NN	B-NP	B-protein
,	,	,	O	O
JARRETT	JARRETT	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
KCL	KCL	NNP	B-NP	O
IMMEDIATE	IMMEDIATE	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39740106	39740106	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LASIX	LASIX	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
NIZORAL	NIZORAL	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
KETOCONAZOLE	KETOCONAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CREAM	CREAM	NN	I-NP	O
TP	TP	NN	I-NP	O
after	after	IN	B-PP	O
shower	shower	NN	B-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
Apply	Apply	RB	B-ADVP	O
under	under	IN	B-PP	O
breasts	breast	NNS	B-NP	O
after	after	IN	B-PP	O
shower	shower	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
qd	qd	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
most	most	RBS	B-NP	O
frequent	frequent	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
7/14/05	7/14/05	CD	B-NP	O
by	by	IN	B-PP	O
KEIPER	KEIPER	NNP	B-NP	O
,	,	,	O	O
DEWAYNE	DEWAYNE	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ATIVAN	ATIVAN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
04628846	04628846	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
KETOCONAZOLE	KETOCONAZOLE	NNP	B-NP	O
,	,	,	I-NP	O
ORAL	ORAL	NNP	I-NP	O
&	&	CC	I-NP	O
LORAZEPAM	LORAZEPAM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
MG	MG	NN	I-NP	O
GLUCONATE	GLUCONATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
GLUCONATE	GLUCONATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
METHADONE	METHADONE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
appears	appear	VBZ	B-VP	O
somnolent	somnolent	JJ	B-NP	O
,	,	,	I-NP	O
RR	RR	NN	I-NP	B-protein
<	<	SYM	I-NP	I-protein
10	10	CD	I-NP	I-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
5-10	5-10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
PREDNISONE	PREDNISONE	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QAM	QAM	NNP	I-NP	O
KCL	KCL	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
20	20	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
As	As	IN	B-PP	O
per	per	IN	B-PP	O
GVMC	GVMC	NNP	B-NP	B-cell_type
Potassium	Potassium	NNP	I-NP	O
Chloride	Chloride	NNP	I-NP	O
Policy	Policy	NNP	I-NP	O
:	:	:	O	O
each	each	DT	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
4	4	CD	B-NP	O
oz	oz	NN	I-NP	O
of	of	IN	B-PP	O
fluid	fluid	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
by	by	IN	B-PP	O
DERIGGI	DERIGGI	NNP	B-NP	O
,	,	,	O	O
LUKE	LUKE	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ENALAPRIL	ENALAPRIL	NNP	B-NP	O
MALEATE	MALEATE	NNP	I-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
,	,	,	I-NP	O
good	good	JJ	I-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
K	K	NN	I-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	B-protein
ADVAIR	ADVAIR	NN	I-NP	I-protein
DISKUS	DISKUS	VBZ	B-VP	O
500/50	500/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
CALTRATE	CALTRATE	NN	I-NP	O
+	+	SYM	B-NP	O
D	D	NN	I-NP	O
-LRB-	-LRB-	SYM	O	O
CALCIUM	CALCIUM	NN	B-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
600	600	CD	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
DUONEB	DUONEB	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NNP	I-NP	O
AND	AND	CC	O	O
IPRATROPIUM	IPRATROPIUM	NNP	B-NP	O
NEBULIZER	NEBULIZER	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
3/0	3/0	CD	I-NP	O
.5	.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
NEB	NEB	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
BACTRIM	BACTRIM	NNP	I-NP	O
DS	DS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRIMETHOPRIM/SULFAMETHOXAZOLE	TRIMETHOPRIM/SULFAMETHOXAZOLE	NNP	I-NP	O
DOU	DOU	NNP	I-NP	O
...	...	:	O	B-DNA
-RRB-	-RRB-	SYM	B-NP	I-DNA
1	1	CD	I-NP	I-DNA
TAB	TAB	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
3x/Week	3x/Week	NN	I-NP	I-DNA
M-W-F	M-W-F	NN	I-NP	I-DNA
DILTIAZEM	DILTIAZEM	NN	I-NP	I-DNA
EXTENDED	EXTENDED	VBD	B-VP	I-DNA
RELEASE	RELEASE	NN	B-NP	I-DNA
90	90	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Debroux	Debroux	NNP	I-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
LOBSTER	LOBSTER	NN	B-NP	O
,	,	,	O	O
FLOWERS	FLOWERS	NN	B-NP	O
,	,	,	O	O
STUFFED	STUFFED	VBD	B-VP	O
ANIMALS	ANIMALS	NNP	B-NP	O
,	,	,	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
,	,	,	O	O
LORATADINE	LORATADINE	NNP	B-NP	O
,	,	,	O	O
FEXOFENADINE	FEXOFENADINE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
MONTELUKAST	MONTELUKAST	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
Cellulitis	Cellulitis	NNP	B-NP	O
,	,	,	O	O
Syncope	Syncope	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
evaluation	evaluation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
HTN	HTN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
OSA	OSA	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
sleep	sleep	NN	I-NP	I-protein
apnea	apnea	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Morbid	Morbid	NNP	I-NP	I-protein
obesity	obesity	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
obesity	obesity	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Depression	Depression	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
depression	depression	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Rx	Rx	NN	I-NP	I-protein
opioid	opioid	JJ	I-NP	I-protein
abuse	abuse	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
substance	substance	NN	I-NP	I-protein
abuse	abuse	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Asthma	Asthma	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
asthma	asthma	NN	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
LBP	LBP	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
low	low	JJ	I-NP	I-protein
back	back	JJ	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
Adhesive	Adhesive	JJ	I-NP	O
capsulitis	capsulitis	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
adhesive	adhesive	JJ	I-NP	O
capsulitis	capsulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Bilat	Bilat	NN	I-NP	O
rotator	rotator	NN	I-NP	O
cuff	cuff	NN	I-NP	O
tear	tear	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
rotator	rotator	NN	I-NP	O
cuff	cuff	NN	I-NP	O
tear	tear	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

PFTs	PFT	NNS	B-NP	O
:	:	:	O	O
results	result	NNS	B-NP	O
pending	pende	VBG	B-PP	O
2	2	CD	B-NP	O
.	.	.	O	O

TnI	TnI	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
x2	x2	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
yo	yo	NN	I-NP	O
morbidly	morbidly	RB	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
,	,	,	O	O
?	?	.	O	O

syncope	syncope	NN	B-NP	O
,	,	,	I-NP	O
SOB	SOB	NN	I-NP	O
DDx	DDx	NN	I-NP	O
:	:	:	O	O
SOB-restrictive	SOB-restrictive	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
+	+	SYM	B-NP	O
asthma	asthma	NN	I-NP	O
Syncope-vasovagal	Syncope-vasovagal	JJ	B-ADJP	O
vs.	vs.	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
2/2	2/2	CD	I-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
51	51	CD	B-NP	O
o	o	NN	I-NP	O
African-American	African-American	JJ	B-ADJP	O
,	,	,	O	O
morbidly	morbidly	RB	B-NP	O
obese	obese	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
on	on	IN	B-PP	O
abdomen	abdomen	NN	B-NP	O
tx	tx	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
10d	10d	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Keflex	Keflex	NNP	B-NP	O
w/improvement	w/improvement	NN	I-NP	O
but	but	CC	B-CONJP	O
not	not	RB	I-CONJP	O
complete	complete	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
.	.	.	O	O

C/o	C/o	NN	B-NP	O
subjective	subjective	JJ	I-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

Syncopal	Syncopal	JJ	B-NP	O
episode	episode	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
3dPTA	3dPTA	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
after	after	IN	B-PP	O
getting	get	VBG	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
car	car	NN	B-NP	B-protein
on	on	IN	B-PP	O
very	very	RB	B-NP	O
hot	hot	JJ	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Unclear	Unclear	JJ	B-NP	O
memory	memory	NN	I-NP	O
of	of	IN	B-PP	O
event	event	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
denies	deny	VBZ	B-VP	O
CP/SOB	CP/SOB	NN	B-NP	B-protein
.	.	.	O	O

Many	Many	JJ	B-NP	O
previous	previous	JJ	I-NP	O
mechanical	mechanical	JJ	I-NP	O
falls	fall	NNS	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
pt	pt	JJ	B-NP	O
c/o	c/o	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
past	past	JJ	B-NP	O
month	month	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
HTN	HTN	NN	B-NP	B-protein
.	.	.	O	O

60mg	60mg	LS	B-NP	O
qd	qd	NN	I-NP	O
prednisone	prednisone	NN	I-NP	O
for	for	IN	B-PP	O
last	last	JJ	B-NP	B-protein
several	several	JJ	I-NP	I-protein
months	month	NNS	I-NP	I-protein
2/2	2/2	CD	B-NP	I-protein
SOB	SOB	NN	I-NP	I-protein
.	.	.	O	O

Began	Began	JJ	B-NP	O
taper	taper	NN	I-NP	O
on	on	IN	B-PP	O
11/19	11/19	CD	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
40qd	40qd	NN	B-NP	O
.	.	.	O	O

Has	Has	NNP	B-NP	O
had	have	VBD	B-VP	O
4	4	CD	B-NP	O
MICU	MICU	NN	I-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
intubations	intubation	NNS	I-NP	O
.	.	.	O	O

Vitals	Vital	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NNP	I-NP	O
were	be	VBD	B-VP	O
98.1	98.1	CD	B-NP	O
HR	HR	NN	I-NP	O
86	86	CD	B-NP	O
RR18	RR18	NN	I-NP	O
BP	BP	NN	I-NP	O
148/90	148/90	CD	I-NP	O
O2Sat94	O2Sat94	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
Lasix	Lasix	NNP	I-NP	O
and	and	CC	O	O
1g	1g	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
Cefazolin	Cefazolin	NN	I-NP	I-protein
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAM	EXAM	NNP	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
Tm97	Tm97	NN	B-NP	O
.8	.8	CD	I-NP	O
Tc97	Tc97	NN	I-NP	O
.7	.7	NN	I-NP	O
HR	HR	NN	I-NP	O
70-90	70-90	CD	I-NP	O
BP115-152	BP115-152	NN	I-NP	O
/	/	SYM	B-NP	O
60-80	60-80	CD	B-NP	O
RR20	RR20	NN	I-NP	O
O2sat96RA	O2sat96RA	NN	I-NP	O
Gen	Gen	NN	I-NP	O
:	:	:	O	O
pleasant	pleasant	NN	B-NP	O
,	,	,	O	O
somnolent	somnolent	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
arousable	arousable	JJ	I-ADJP	O
,	,	,	B-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
HEENT	HEENT	NN	I-NP	O
:	:	:	O	O
EOMI	EOMI	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
L	L	NN	B-NP	O
eye	eye	NN	I-NP	O
drifts	drift	NNS	I-NP	O
outward	outward	RB	B-ADVP	O
with	with	IN	B-PP	O
somnolence	somnolence	NN	B-NP	O
CHEST	CHEST	NN	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
but	but	CC	O	O
distant	distant	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
COR	COR	NN	B-NP	O
:	:	:	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
nml	nml	NN	B-NP	B-protein
S1	S1	NN	I-NP	I-protein
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
M/R/G	M/R/G	NNP	I-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
erythema	erythema	NN	I-NP	O
on	on	IN	B-PP	O
inferior	inferior	JJ	B-NP	O
edge	edge	NN	I-NP	O
of	of	IN	B-PP	O
pannus	pannus	NN	B-NP	O
,	,	,	O	O
stable	stable	JJ	B-ADJP	O
since	since	IN	B-PP	O
yesterday	yesterday	NN	B-NP	O
.	.	.	O	O

Scattered	Scatter	VBN	B-VP	O
blanching	blanch	VBG	B-VP	O
spots	spot	NNS	B-NP	O
of	of	IN	B-PP	O
erythema	erythema	NN	B-NP	O
underneath	underneath	NN	I-NP	O
breasts	breast	NNS	I-NP	O
with	with	IN	B-PP	O
white	white	JJ	B-NP	O
crusting	crust	VBG	I-NP	O
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
mid-shins	mid-shin	NNS	B-NP	O
,	,	,	O	O
=	=	SYM	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Some	Some	DT	B-NP	O
blanching	blanch	VBG	I-NP	O
erythema	erythema	NN	I-NP	O
on	on	IN	B-PP	O
ant	ant	JJ	B-NP	O
surface	surface	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
pulses	pulse	NNS	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
INVESTIGATIONS	INVESTIGATIONS	NNS	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
NOTE	NOTE	NN	B-NP	O
:	:	:	O	O
WBC	WBC	NN	B-NP	B-cell_type
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
2/2	2/2	CD	I-NP	O
steroid	steroid	NN	I-NP	O
use	use	NN	I-NP	O
CK	CK	NN	I-NP	O
:	:	:	O	O
471	471	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
=	=	SYM	B-VP	O
baseline	baseline	NN	B-NP	O
-RRB-	-RRB-	SYM	B-VP	O
TnI	TnI	NN	B-NP	O
#	#	#	I-NP	O
1	1	CD	I-NP	O
<	<	SYM	I-NP	O
assay	assay	NN	I-NP	O
Echo	Echo	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
5/30	5/30	CD	I-NP	O
EF	EF	NN	I-NP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
MR	MR	NN	I-NP	O
PFTs	PFT	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
'01	'01	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
FVC	FVC	NN	B-NP	O
:	:	:	O	O
74	74	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
FEV1	FEV1	NN	B-NP	O
:	:	:	O	O
72	72	CD	B-NP	O
,	,	,	O	O
FEV1/FVC	FEV1/FVC	NN	B-NP	O
:	:	:	O	O
97	97	CD	B-NP	O
CXR	CXR	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
8/9/05	8/9/05	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
interstitial	interstitial	JJ	I-NP	O
prominence	prominence	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
?	?	.	O	O

vasc	vasc	NN	B-NP	O
engorgement	engorgement	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Wrist	Wrist	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
5/20/05	5/20/05	CD	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
No	No	DT	B-NP	O
acute	acute	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
,	,	,	O	O
interval	interval	JJ	B-NP	O
healing	healing	NN	I-NP	O
of	of	IN	B-PP	O
old	old	JJ	B-NP	O
fx	fx	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	O
PFTs	PFT	NNS	I-NP	O
:	:	:	O	O
Pending	Pende	VBG	B-VP	O
at	at	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
dicharge	dicharge	NN	B-NP	O
summary	summary	NN	I-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
ASSESSMENT/PLAN	ASSESSMENT/PLAN	NN	B-NP	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
--	--	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Syncope	Syncope	NN	B-NP	O
:	:	:	O	O
Likely	Likely	JJ	B-NP	O
orthostasis	orthostasis	NN	I-NP	O
by	by	IN	B-PP	O
history	history	NN	B-NP	O
.	.	.	O	O

TnI	TnI	NN	B-NP	B-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
EKG	EKG	NNP	B-NP	O
NSR	NSR	NNP	I-NP	O
,	,	,	O	O
metabolic	metabolic	JJ	B-NP	O
panel	panel	NN	I-NP	O
wnl	wnl	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Cellulitis	Cellulitis	NN	B-NP	O
not	not	RB	B-ADJP	O
impressive	impressive	JJ	I-ADJP	O
.	.	.	O	O

Cefazolin	Cefazolin	NN	B-NP	O
x2d	x2d	NN	I-NP	O
,	,	,	O	O
switch	switch	NN	B-NP	O
to	to	TO	B-PP	O
Augmentin	Augmentin	NNP	B-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
d	d	NN	I-NP	O
total	total	JJ	I-NP	O
course	course	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
h/o	h/o	VB	B-VP	O
severe	severe	JJ	B-NP	O
``	``	``	I-NP	O
asthma	asthma	NN	I-NP	O
''	''	''	O	O
,	,	,	O	O
but	but	CC	O	O
PFTs	PFT	NNS	B-NP	O
c/w	c/w	VBP	B-VP	O
restrictive	restrictive	JJ	B-NP	O
picture	picture	NN	I-NP	O
.	.	.	O	O

PFts	PFt	NNS	B-NP	O
repeated	repeat	VBN	B-VP	O
,	,	,	O	O
f/u	f/u	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
with	with	IN	B-PP	O
pulm	pulm	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

CV	CV	NN	B-NP	O
:	:	:	O	O
Likely	Likely	RB	B-NP	O
some	some	DT	I-NP	O
LHF	LHF	NN	I-NP	B-protein
2/2	2/2	CD	I-NP	I-protein
HTN	HTN	NN	I-NP	I-protein
and	and	CC	I-NP	O
RHF	RHF	NN	I-NP	B-protein
2/2	2/2	CD	I-NP	I-protein
chronic	chronic	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

Diltiazem	Diltiazem	NNP	B-NP	O
added	add	VBD	B-VP	O
for	for	IN	B-PP	O
HTN/diastolic	HTN/diastolic	JJ	B-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
breathing	breathing	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Continue	Continue	NNP	B-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
meds	med	NNS	I-NP	O
6	6	CD	B-NP	O
.	.	.	O	O

Electrolytes	Electrolyte	NNS	B-NP	O
:	:	:	O	O
Long-acting	Long-acting	JJ	B-NP	O
K	K	NN	I-NP	O
+	+	SYM	B-NP	O
to	to	TO	B-PP	O
supplement	supplement	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
increase	increase	NN	B-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

God	God	NNP	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
************	************	SYM	B-NP	O
ADDENDUM	ADDENDUM	NN	I-NP	O
***************	***************	SYM	I-NP	O
Pt	Pt	NN	I-NP	O
left	leave	VBD	B-VP	O
room	room	NN	B-NP	O
several	several	JJ	I-NP	O
timse	timse	NN	I-NP	O
afte	afte	NN	I-NP	O
rattempts	rattempt	NNS	I-NP	O
to	to	TO	B-VP	O
do	do	VB	I-VP	O
PFTs	PFT	NNS	B-NP	B-protein
.	.	.	O	O

Spoke	Spoke	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
Dr.	Dr.	NNP	B-NP	O
Mccumiskey	Mccumiskey	NNP	I-NP	O
who	who	WP	B-NP	O
said	say	VBD	B-VP	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
noncompliant	noncompliant	JJ	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
appts	appt	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
restart	restart	VB	B-VP	O
all	all	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
EXCEPT	EXCEPT	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
changes	change	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Augmentin	Augmentin	NNP	B-NP	O
:	:	:	O	O
Please	Please	NNP	B-NP	O
take	take	VB	B-VP	O
Augmentin	Augmentin	NNP	B-NP	O
3x	3x	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
:	:	:	O	O
We	We	PRP	B-NP	O
have	have	VBP	B-VP	O
increased	increase	VBN	I-VP	O
your	your	PRP$	B-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
every	every	DT	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Diltiazem	Diltiazem	NN	B-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
BP	BP	NN	B-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Take	Take	VB	B-VP	O
a	a	DT	B-NP	O
30mg	30mg	JJ	I-NP	O
tablet	tablet	NN	I-NP	O
,	,	,	O	O
3x	3x	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Slow	Slow	JJ	B-NP	O
release	release	NN	I-NP	O
Potassium	Potassium	NN	I-NP	O
to	to	TO	B-PP	O
supplement	supplement	NN	B-NP	B-DNA
5	5	CD	I-NP	I-DNA
.	.	.	O	O

Continue	Continue	VB	B-VP	O
your	your	PRP$	B-NP	O
steroid	steroid	NN	I-NP	O
taper	taper	NN	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
ad	ad	VBP	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Prach	Prach	NNP	I-NP	O
discussed	discuss	VBD	B-VP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Finish	Finish	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Augmentin	Augmentin	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Pulmonologist	Pulmonologist	NN	B-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
BRIDGFORD	BRIDGFORD	NN	B-NP	O
,	,	,	O	O
STEVE	STEVE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
4/19/05	4/19/05	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
11	11	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

